Skip to main content
. 2017 Aug 6;8(40):66925–66939. doi: 10.18632/oncotarget.19963

Figure 2. Traditional markers (CA125 and PCNA) predict poor overall survival in ovarian cancer patients.

Figure 2

We assessed the predictive value of CA125 and PCNA in N = 111 ovarian cancer patients, with optimal de-bulking. Note that high transcript levels of CA125 and PCNA are associated with significantly reduced overall survival.